Shentova-Eneva RR, Kofinova DR, Baycheva MZ, Hadzhiyski PG, Naydenov HB, Yaneva PG, Lazarova EA. Anti-tumor necrosis factor therapy in Bulgarian pediatric patients with inflammatory bowel disease - an 8-year experience of a referral center.
Folia Med (Plovdiv) 2023;
65:605-611. [PMID:
37655379 DOI:
10.3897/folmed.65.e84368]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2022] [Accepted: 06/10/2022] [Indexed: 09/02/2023] Open
Abstract
INTRODUCTION
Anti-tumor necrosis factor (anti-TNF) therapy has become a mainstay in the treatment of patients with inflammatory bowel disease over the past few decades.
Collapse